SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-022424
Filing Date
2018-04-25
Accepted
2018-04-25 17:01:15
Documents
5
Period of Report
2018-06-06
Effectiveness Date
2018-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv491717_def14a.htm DEF 14A 789705
2 GRAPHIC tv491717_img1.jpg GRAPHIC 27439
3 GRAPHIC tv491717_img2.jpg GRAPHIC 12637
4 GRAPHIC tv491717_proxy1.jpg GRAPHIC 247418
5 GRAPHIC tv491717_proxy2.jpg GRAPHIC 201726
  Complete submission text file 0001144204-18-022424.txt   1465285
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36860 | Film No.: 18775037
SIC: 2836 Biological Products, (No Diagnostic Substances)